Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Diabetes, Gestational"

Article category

Keywords

Publication year

"Diabetes, Gestational"

Original Article

Steatotic liver disease

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park
Clin Mol Hepatol 2022;28(1):105-116.
Published online October 15, 2021
DOI: https://doi.org/10.3350/cmh.2021.0174
Background/Aims
To develop an early prediction model for gestational diabetes mellitus (GDM) using machine learning and to evaluate whether the inclusion of nonalcoholic fatty liver disease (NAFLD)-associated variables increases the performance of model.
Methods
This prospective cohort study evaluated pregnant women for NAFLD using ultrasound at 10–14 weeks and screened them for GDM at 24–28 weeks of gestation. The clinical variables before 14 weeks were used to develop prediction models for GDM (setting 1, conventional risk factors; setting 2, addition of new risk factors in recent guidelines; setting 3, addition of routine clinical variables; setting 4, addition of NALFD-associated variables, including the presence of NAFLD and laboratory results; and setting 5, top 11 variables identified from a stepwise variable selection method). The predictive models were constructed using machine learning methods, including logistic regression, random forest, support vector machine, and deep neural networks.
Results
Among 1,443 women, 86 (6.0%) were diagnosed with GDM. The highest performing prediction model among settings 1–4 was setting 4, which included both clinical and NAFLD-associated variables (area under the receiver operating characteristic curve [AUC] 0.563–0.697 in settings 1–3 vs. 0.740–0.781 in setting 4). Setting 5, with top 11 variables (which included NAFLD and hepatic steatosis index), showed similar predictive power to setting 4 (AUC 0.719–0.819 in setting 5, P=not significant between settings 4 and 5).
Conclusions
We developed an early prediction model for GDM using machine learning. The inclusion of NAFLDassociated variables significantly improved the performance of GDM prediction. (ClinicalTrials.gov Identifier: NCT02276144)

Citations

Citations to this article as recorded by  Crossref logo
  • Artificial intelligence methods in gestational diabetes mellitus prediction: A systematic literature review
    Valentina Ivanovic, Md Abu Jafar Sujan, Ole Jakob Mengshoel, Trine Moholdt
    International Journal of Medical Informatics.2026; 206: 106158.     CrossRef
  • What role does metabolic disfunction-associated fatty liver disease play in the metabolic landscape of pregnancy?
    Annunziata Lapolla, Maria Grazia Dalfrà
    Expert Review of Endocrinology & Metabolism.2026; 21(1): 1.     CrossRef
  • Predictive Performance of Artificial Intelligence Algorithms for Gestational Diabetes Mellitus in Pregnant Women: Systematic Review and Meta-Analysis
    Yingni Liang, Anran Dai, Meiyan Luo, Zhuolian Zheng, Jiayu Shen, Yinhua Su, Zhongyu Li
    Journal of Medical Internet Research.2026; 28: e79729.     CrossRef
  • Metabolic factor-based machine learning model for mortality prediction in acute hepatitis E: Development and validation from a dual-center cohort
    Haoshuang Fu, Shuying Song, Yuelin Xiao, Bingying Du, Gangde Zhao, Tianhui Zhou, Yanan Du
    Digestive and Liver Disease.2026; 58(5): 660.     CrossRef
  • Sucralose Exposure During Pregnancy Elevates Gestational Diabetes Risk via Gut Microbiota‐Metabolic Axis in Mice
    Jiajia Song, Juhui He, Zhaoxia Liang, Hannah Wesley
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Establishment of a predictive model for spontaneous preterm birth in primiparas with grade A1 gestational diabetes mellitus
    Ting Sun, Yangyang Zhang, Chunzhi Xie, Anyi Teng, Shi Lin, Hui Zhang, Yan Li
    Frontiers in Global Women's Health.2025;[Epub]     CrossRef
  • Machine learning based model for the early detection of Gestational Diabetes Mellitus
    Hesham Zaky, Eleni Fthenou, Luma Srour, Thomas Farrell, Mohammed Bashir, Nady El Hajj, Tanvir Alam
    BMC Medical Informatics and Decision Making.2025;[Epub]     CrossRef
  • Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosis
    Youngae Jung, Seung Mi Lee, Jinhaeng Lee, Yeonjin Kim, Woojoo Lee, Ja Nam Koo, Ig Hwan Oh, Kue Hyun Kang, Byoung Jae Kim, Sun Min Kim, Jeesun Lee, Ji Hoi Kim, Yejin Bae, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Dong Hyeon Lee, Joon Ho Moon, Bo Kyung
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • GDM-BC: Non-invasive body composition dataset for intelligent prediction of Gestational Diabetes Mellitus
    Chen Zheng, Tong Qing, Mao Li, Shujuan Liao, Biru Luo, Chenwei Tang, Jiancheng Lv
    Computers in Biology and Medicine.2025; 192: 110176.     CrossRef
  • Metabolic dysfunction–associated steatotic liver disease and pregnancy
    Monika Sarkar, Tatyana Kushner
    Journal of Clinical Investigation.2025;[Epub]     CrossRef
  • Maternal liver fibrosis indices as predictors of adverse perinatal outcomes in patients with gestational diabetes mellitus
    Murad Gezer, Ümit Taşdemir, Ömer Gökhan Eyisoy, Sevdenur Yiğit, Mucize Eriç Özdemir, Oya Demirci
    Acta Diabetologica.2025; 62(12): 2055.     CrossRef
  • Associations of hepatic steatosis index in early pregnancy with perinatal outcomes: A prospective birth cohort study
    Shaofei Su, Enjie Zhang, Shen Gao, Yue Zhang, Jianhui Liu, Shuanghua Xie, Jinghan Yu, Qiutong Zhao, Wentao Yue, Ruixia Liu, Chenghong Yin
    Clinical Medicine.2025; 25(4): 100343.     CrossRef
  • Artificial Intelligence in Gestational Diabetes Care: A Systematic Review
    Rawan AlSaad, Ali Elhenidy, Aliya Tabassum, Nour Odeh, Eman AboArqoub, Aya Odeh, Maya AlTamimi, Alaa Abd-alrazaq, Rajat Thomas, Mohammed Bashir, Javaid Sheikh
    Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef
  • Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions
    Mohamad Jamalinia, Samira Saeian, Nima Nikkhoo, Amirhossein Nazerian, Kamran Bagheri Lankarani
    Metabolism and Target Organ Damage.2025;[Epub]     CrossRef
  • Evaluating the performance of maternal risk factors in predicting gestational diabetes mellitus: a systematic review and meta-analysis
    Alemu Degu Ayele, Getnet Gedefaw Azeze, Beklau Kassie Alemu, Yao Wang, Chi Chiu Wang
    BMJ Evidence-Based Medicine.2025; : bmjebm-2025-114065.     CrossRef
  • Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide study
    Young Mi Jung, Seung Mi Lee, Wonyoung Wi, Min-Jeong Oh, Joong Shin Park, Geum Joon Cho, Won Kim
    JHEP Reports.2024; 6(4): 101033.     CrossRef
  • The early prediction of gestational diabetes mellitus by machine learning models
    Yeliz Kaya, Zafer Bütün, Özer Çelik, Ece Akça Salik, Tuğba Tahta, Arzu Altun Yavuz
    BMC Pregnancy and Childbirth.2024;[Epub]     CrossRef
  • Could Machine Learning-Based Gestational Diabetes Mellitus Prediction Models Replace Traditional Screening Test?
    Jong Yun Hwang
    Journal of Korean Maternal and Child Health.2024; 28(4): 153.     CrossRef
  • The Role of Adiponectin during Pregnancy and Gestational Diabetes
    Brittany L. Moyce Gruber, Vernon W. Dolinsky
    Life.2023; 13(2): 301.     CrossRef
  • Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women
    Ping Wu, Yi Wang, Yi Ye, Xue Yang, Yichao Huang, Yixiang Ye, Yuwei Lai, Jing Ouyang, Linjing Wu, Jianguo Xu, Jiaying Yuan, Yayi Hu, Yi-Xin Wang, Gang Liu, Da Chen, An Pan, Xiong-Fei Pan
    BMC Medicine.2023;[Epub]     CrossRef
  • Performance Analysis and Assessment of Type 2 Diabetes Screening Scores in Patients with Non-Alcoholic Fatty Liver Disease
    Norma Latif Fitriyani, Muhammad Syafrudin, Siti Maghfirotul Ulyah, Ganjar Alfian, Syifa Latif Qolbiyani, Chuan-Kai Yang, Jongtae Rhee, Muhammad Anshari
    Mathematics.2023; 11(10): 2266.     CrossRef
  • Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes
    Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H. Wild, Christopher D. Byrne
    European Journal of Epidemiology.2023; 38(8): 901.     CrossRef
  • Identification of influence factors in overweight population through an interpretable risk model based on machine learning: a large retrospective cohort
    Wei Lin, Songchang Shi, Huiyu Lan, Nengying Wang, Huibin Huang, Junping Wen, Gang Chen
    Endocrine.2023; 83(3): 604.     CrossRef
  • Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
    Seung Mi Lee, Won Kim
    Clinical and Molecular Hepatology.2022; 28(1): 47.     CrossRef
  • 12,707 View
  • 272 Download
  • 24 Web of Science
  • Crossref